
Catalyst Pharmaceuticals Inc (CPRX) receives an Outperform rating from Robert W. Baird
Catalyst Pharmaceuticals Inc’s recently made public that its Officer Elsbernd Brian acquired Company’s shares for reported $0.61 million on Sep
Catalyst Pharmaceuticals Inc’s recently made public that its Officer Elsbernd Brian acquired Company’s shares for reported $0.61 million on Sep
In a filing, Catalyst Pharmaceuticals Inc revealed its Director Tierney David S unloaded Company’s shares for reported $0.53 million on
Catalyst Pharmaceuticals Inc’s filing revealed that its Officer Miller Steve acquired Company’s shares for reported $2.33 million on Aug 26
Catalyst Pharmaceuticals Inc’s filing revealed that its Chief Strategy Officer Sundaram Preethi unloaded Company’s shares for reported $61377.0 on Jun
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Catalyst Pharmaceuticals Inc’s filing revealed that its Chief Strategy Officer Sundaram Preethi unloaded Company’s shares for reported $61377.0 on Jun
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Catalyst Pharmaceuticals
In a filing, Catalyst Pharmaceuticals Inc revealed its Chief Strategy Officer Sundaram Preethi unloaded Company’s shares for reported $61377.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its